EUVIMEDOpdag EUVIMED
Open access · CC BY 4.0

Network Pharmacology Reveals the Potential Mechanism of Ketamine in Improving Cognitive Impairment in Patients With Depression

Network Pharmacology zeigt den potenziellen Mechanismus von Ketamin zur Verbesserung kognitiver Beeinträchtigung bei Patient:innen mit Depression

Lei Yang, Qiuyu Zhang, Ying Zhang, Kaifang Yao, Ximing Chen, Hongjun Tian, Chuanjun Zhuo iD

Alpha Psychiatry · 2026-08-06 · 27 (4)

DOI: 10.31083/ap56752 ↗

Auf einen Blick

Die Studie untersuchte mit Netzwerkpharmakologie und Molekulardocking, wie Ketamin kognitive Beeinträchtigung bei Depression beeinflussen könnte. Identifiziert wurden 20 Zielproteine und mehrere Signalwege.

Fragestellung

Wie könnte Ketamin kognitive Beeinträchtigung bei Patient:innen mit Depression auf molekularer Ebene verbessern?

Methode

Bioinformatische Analyse mit Enrichment-Analyse, PPI-Netzwerk und Molekulardocking; Zielinformationen aus OMIM, GeneCards und DisGENET; Ketamin-Ziele aus öffentlichen Datenbanken.

Ergebnisse

20 ketaminbezogene Zielproteine wurden mit Depression und kognitiver Beeinträchtigung verknüpft. Wichtige Signalwege waren „amphetamine addiction“ und „dopaminergic synapse“. Fünf Kern-Gene wurden identifiziert.

Schlussfolgerung der Autor:innen

Die antidepressiven und kognitionsverbessernden Effekte von Ketamin werden nach Ansicht der Autor:innen vor allem über bestimmte Zielstrukturen und Signalwege vermittelt. Die Befunde sollen die klinische Anwendung und neue Arzneientwicklung unterstützen.

Kernaussagen

  • 20 ketaminbezogene Zielproteine mit Depression und kognitiver Beeinträchtigung verknüpft
  • Wichtige Signalwege: „amphetamine addiction“ und „dopaminergic synapse“
  • Fünf Kern-Gene und starke Bindung im Molekulardocking

Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.

At a glance

Journal article in Alpha Psychiatry, published online on 2026-08-06. Written by Lei Yang and 6 co-authors. Institution: Computational Biology and Animal Imaging Center (CBAC), Tianjin Anding Hospital, Nankai University Affiliated Tianjin Anding Hospital, Tianjin Medica…. 70 references. The full text is freely available (open access, CC BY 4.0). Funded by: National Natural Science Foundation of China.

Auf einen BlickAbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background

Ketamine may have antidepressant and anti-suicidal effects. However, the mechanism underlying ketamine-mediated improvement in cognitive impairment in patients with depression remains unclear. To improve patient cognition in depression using molecular docking and network pharmacology, we examined ketamine's key targets and identified its molecular mechanisms.

Methods

To gain target information about cognitive impairment (1983) and depression (1874), we used three databases, including Online Mendelian Inheritance in Man, GeneCards, and DisGENET. Information on ketamine targets (63) was retrieved from public databases. To locate signaling pathways and core targets, we conducted bioinformatics analysis, including an enrichment analysis and protein–protein interaction (PPI) network analysis. To assess the interaction between core targets and ketamine, we carried out molecular docking.

Results

We identified 20 ketamine target proteins of ketamine related to depression and cognitive impairment. Enrichment analyses revealed that ketamine influenced depression and cognitive function through multiple pathways, targets, and overall synergy. The important signaling pathways identified were “amphetamine addiction” and “dopaminergic synapse”. Five core genes (monoamine oxidase (MAO)-A, MAO-B, glycogen synthase kinase-3β, sirtuin-1, epidermal growth factor receptor) were identified through PPI-network analyses. Our molecular docking results showed that binding was strong between these core genes and ketamine.

Conclusions

The antidepressant and cognitive-enhancing effects of ketamine are primarily mediated through targets associated with inflammation, neural signaling, tumors, and neurodegeneration, as well as pathways such as amphetamine addiction, dopaminergic synapse, and the cyclic adenosine monophosphate (cAMP) signaling pathway. The findings provide theoretical support and guidance for optimizing clinical application strategies of ketamine and for designing new drugs.

Subjects

Author keywords

cognitive impairmentdepressionketaminemolecular dockingnetwork pharmacology

Authors and institutions

  • Computational Biology and Animal Imaging Center (CBAC), Tianjin Anding Hospital, Nankai University Affiliated Tianjin Anding Hospital, Tianjin Medical University Affiliated Tianjin Anding Hospital, Tianjin Medical Unive…
  • Laboratory of Psychiatric-Neuroimaging-Genetic and Co-morbidity (PNGC_Lab), Tianjin Anding Hospital, Tianjin Mental Health Center of Tianjin Medical University, 300222 Tianjin, China.
  • Department of Psychiatry, Tianjin Fourth Center Hospital, Nankai University Affiliated Tianjin Fourth Center Hospital, 300140 Tianjin, China.

ORCID profiles: Chuanjun Zhuo

Funding

  • National Natural Science Foundation of China

Cite

APA

Yang, L., Zhang, Q., Zhang, Y., Yao, K., Chen, X., Tian, H., & Zhuo, C. (2026). Network Pharmacology Reveals the Potential Mechanism of Ketamine in Improving Cognitive Impairment in Patients With Depression. Alpha Psychiatry, 27(4). https://doi.org/10.31083/ap56752

Vancouver

Yang L, Zhang Q, Zhang Y, Yao K, Chen X, Tian H, et al. Network Pharmacology Reveals the Potential Mechanism of Ketamine in Improving Cognitive Impairment in Patients With Depression. Alpha Psychiatry. 2026;27(4). doi:10.31083/ap56752

BibTeX
@article{Yang2026,
  author = {Yang, Lei and Zhang, Qiuyu and Zhang, Ying and Yao, Kaifang and Chen, Ximing and Tian, Hongjun and Zhuo, Chuanjun},
  title = {Network Pharmacology Reveals the Potential Mechanism of Ketamine in Improving Cognitive Impairment in Patients With Depression},
  journal = {Alpha Psychiatry},
  year = {2026},
  volume = {27},
  number = {4},
  doi = {10.31083/ap56752}
}
Start for free →